Mitsubishi Electric Reorganizes Particle Therapy Business Operations for
Expansion Into Global Markets
Providing a full line of proton, carbon and proton-plus-carbon particle
TOKYO -- June 10, 2014
Mitsubishi Electric Corporation (TOKYO: 6503) announced today that under a
strategy to expand its successful particle therapy business in Japan into
global markets, it has formed a medical system global marketing group at its
Tokyo headquarters and a particle therapy medical group at Mitsubishi Electric
Power Products, Inc. (MEPPI), a U.S.-based subsidiary.
A team in the new medical system global marketing group in Tokyo is now
studying marketing opportunities in the global medical markets, including
analysis of specific markets to adapt solutions to local needs. As part of
this effort, a fully operational proton accelerator has been installed at
Energy Systems Center in Kobe to test innovations in a controlled laboratory.
This eliminates the need to rely on the use of customers clinical systems to
validate new developments, and will give clinics the added assurance of
knowing that these solutions were tested fully and rigorously prior to
In addition to the focus at headquarters, a team of several experts has been
dispatched to establish the particle therapy medical group in the Warrendale,
Pennsylvania headquarters of MEPPI, which has been successful in the
introduction of other high technology products in the American markets.
Global medical device Quality Management System establishment and maintenance
project group, a dedicated regulatory group, also has been established to
address specific requirements in each country. The process of preparing
documents for US FDA 510k clearance is underway, backed by two decades of
experience and clinical data.
Mitsubishi Electric, the leading supplier of particle therapy systems in
Japan, provides a full line of proton, carbon and proton-plus-carbon
solutions. The company is the only commercial supplier with such broad,
clinically proven offerings to address the needs of most clinical centers. Its
proton solution, reengineered for cost and compactness, is gaining rapid
acceptance at cancer centers that require a cost-effective, single-room
system. The quality and innovative features of this Mitsubishi Electric
solution has attracted the attention of many institutions worldwide. “I
believe Mitsubishi Electric’s state-of-the-art particle therapy solutions can
contribute to improvement of the cancer patients’ QOL worldwide” said
Shinichiro Yagi, General Manager of Mitsubishi Electric’s Medical Systems
Mitsubishi Electric will issue this announcement during the Particle Therapy
Co-Operative Group (PTCOG) meeting in Shanghai, the site of the only Asian
proton-plus-carbon system outside of Japan. Mitsubishi Electric will use this
opportunity to display its commercially available proton, carbon and
Note: Products mentioned in this release require country-specific regulatory
clearance prior to patient use.
About Mitsubishi Electric Power Products, Inc.
Headquartered in Warrendale, Penn., Mitsubishi Electric Power Products, Inc.
is a US affiliate of Mitsubishi Electric Corporation of Japan, and serves the
North American power systems, rail transportation and water treatment
industries with electrical and electronic products, systems and services.
Products include gas circuit breakers, vacuum circuit breakers, power
transformers, gas insulated sub-stations, power electronics and electricity
transmission technologies, generator services, ozone water treatment systems,
uninterruptible power supplies and rail transportation equipment. Information
on Mitsubishi Electric Power Products’ complete line of products and services
can be found at www.MEPPI.com. Mitsubishi Electric Power Products’ Diamond
Vision division markets large-scale video displays for stadiums and arenas,
including the Guinness World Record-holding display at Cowboys Stadium. To
learn more, visit www.Diamond-Vision.com.
About Mitsubishi Electric Corporation
With over 90 years of experience in providing reliable, high-quality products,
Mitsubishi Electric Corporation (TOKYO: 6503) is a recognized world leader in
the manufacture, marketing and sales of electrical and electronic equipment
used in information processing and communications, space development and
satellite communications, consumer electronics, industrial technology, energy,
transportation and building equipment. Embracing the spirit of its corporate
statement, Changes for the Better, and its environmental statement, Eco
Changes, Mitsubishi Electric endeavors to be a global, leading green company,
enriching society with technology. The company recorded consolidated group
sales of 4,054.3 billion yen (US$ 39.3 billion*) in the fiscal year ended
March 31, 2014. For more information visit http://www.MitsubishiElectric.com
*At an exchange rate of 103 yen to the US dollar, the rate given by the Tokyo
Foreign Exchange Market on March 31, 2014
Mitsubishi Electric Corporation
Medical Systems Marketing Department
Katsunobu Muroi, +81-3-3218-2346
Public Relations Division
Press spacebar to pause and continue. Press esc to stop.